These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A]. Egizova SA; Deriabin PN; Karal'nik BV; Kanapina ASh; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):38-41. PubMed ID: 3149841 [TBL] [Abstract][Full Text] [Related]
23. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection. Sharma S; Kaur R; Yadav V; Harjai K; Joshi K Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223 [TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa exotoxin A primes human monocyte oxidative burst response in vitro. Patzer J; Nielsen H; Kharazmi A Microb Pathog; 1989 Aug; 7(2):147-52. PubMed ID: 2512464 [TBL] [Abstract][Full Text] [Related]
25. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa. Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869 [TBL] [Abstract][Full Text] [Related]
26. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A]. Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182 [No Abstract] [Full Text] [Related]
27. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections]. Döring G Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018 [TBL] [Abstract][Full Text] [Related]
28. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization. Martinez D; Callahan LT Eur J Clin Microbiol; 1985 Apr; 4(2):186-9. PubMed ID: 3924606 [TBL] [Abstract][Full Text] [Related]
29. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections. Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760 [TBL] [Abstract][Full Text] [Related]
30. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice. Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995 [TBL] [Abstract][Full Text] [Related]
31. Protective activity of anti-exotoxin A monoclonal antibody against mice infected with toxin-producing Pseudomonas aeruginosa. Kohzuki T; Eguchi Y; Kato M; Irie K; Ohtsuka H; Higuchi A; Noguchi H J Infect Dis; 1993 Jan; 167(1):119-25. PubMed ID: 8418158 [TBL] [Abstract][Full Text] [Related]
32. Ulcer bed infection. Report of a case of enlarging venous leg ulcer colonized by Pseudomonas aeruginosa. Danielsen L; Balslev E; Döring G; Høiby N; Madsen SM; Agren M; Thomsen HK; Fos HH; Westh H APMIS; 1998 Jul; 106(7):721-6. PubMed ID: 9740512 [TBL] [Abstract][Full Text] [Related]
33. Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies. Rao AR; Splaingard MS; Gershan WM; Havens PL; Thill A; Barbieri JT Pediatr Pulmonol; 2005 May; 39(5):402-7. PubMed ID: 15666370 [TBL] [Abstract][Full Text] [Related]
34. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections]. Döring G Infection; 1987; 15(1):47-50. PubMed ID: 3106228 [TBL] [Abstract][Full Text] [Related]
35. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa]. Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999 [TBL] [Abstract][Full Text] [Related]
36. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection. Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800 [TBL] [Abstract][Full Text] [Related]
37. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A. Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902 [TBL] [Abstract][Full Text] [Related]
38. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Cryz SJ; Fürer E; Sadoff JC; Germanier R Antibiot Chemother (1971); 1987; 39():249-55. PubMed ID: 3118786 [No Abstract] [Full Text] [Related]